Clinical End Points in Coronary Stent TrialsDonald E. Cutlip, Patrick W. Serruys, Stephan Windecker et al.|Circulation|2007Cited by 5.4k
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research ConsortiumM.B. Leon, Patrick W. Serruys, Nicolò Piazza et al.|European Heart Journal|2011Cited by 1.2k
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHéctor M. García‐García, Patrick W. Serruys, Eugène McFadden et al.|Circulation|2018Cited by 926
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trialPascal Vranckx|The Lancet|2018Cited by 777
Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical TrialsMartin B. Leon, Patrick W. Serruys, Nicolò Piazza et al.|Journal of the American College of Cardiology|2011Cited by 734